Antimicrobial stewardship, clinical microbiologists, critical care, Intensive Care Unit, synergy
Citation Information :
Singh S, Rattan A, Goel N, Nangia V, Manchanda V, Ghosh S, Dhar D, Singh V, Singh O, Wattal C, Saxena S, Oberoi JK, Rao B, Kaur I, Datta S, Gupta SS. Convergence of Minds: For Better Patient Outcome in Intensive Care Unit Infections. Indian J Crit Care Med 2017; 21 (3):154-159.
Background: There is emergence of resistance to the last-line antibiotics such as carbapenems in Intensive Care Units (ICUs), leaving little effective therapeutic options. Since there are no more newer antibiotics in the armamentarium in the near future, it has become imperative that we harness the interdisciplinary knowledge for the best clinical outcome of the patient.
Aims: The aim of the conference was to utilize the synergies between the clinical microbiologists and critical care specialists for better patient care and clinical outcome.
Materials and Methods: A combined continuing medical education program (CME) under the aegis of the Indian Association of Medical Microbiologists – Delhi Chapter and the Indian Society of Critical Care Medicine, Delhi and national capital region was organized to share their expertise on the various topics covering epidemiology, diagnosis, management, and prevention of hospital-acquired infections in ICUs.
Results: It was agreed that synergy between the clinical microbiologists and critical care medicine is required in understanding the scope of laboratory tests, investigative pathway testing, hospital epidemiology, and optimum use of antibiotics. A consensus on the use of rapid diagnostics such as point-of-care tests, matrix-assisted laser desorption ionization-time of flight mass spectrometry, and molecular tests for the early diagnosis of infectious disease was made. It was agreed that stewardship activities along with hospital infection control practices should be further strengthened for better utilization of the antibiotics. Through this CME, we identified the barriers and actionables for appropriate antimicrobial usage in Indian ICUs. Conclusions: A close coordination between clinical microbiology and critical care medicine opens up avenues to improve antimicrobial prescription practices.
Burillo A, Bouza E. Use of rapid diagnostic techniques in ICU patients with infections. BMC Infect Dis 2014;14:593.
Paveenkittiporn W, Kerdsin A, Chokngam S, Bunthi C, Sangkitporn S, Gregory CJ. Emergence of plasmid-mediated colistin resistance and New Delhi metallo-ß-lactamase genes in extensively drug-resistant Escherichia coli isolated from a patient in Thailand. Diagn Microbiol Infect Dis 2017;87:157-9.
Wattal C, Raveendran R, Goel N, Oberoi JK, Rao BK. Ecology of blood stream infection and antibiotic resistance in Intensive Care Unit at a tertiary care hospital in North India. Braz J Infect Dis 2014;18:245-51.
Gill JS, Arora S, Khanna SP, Kumar KH. Prevalence of multidrug-resistant, extensively drug-resistant, and pandrug-resistant Pseudomonas aeruginosa from a tertiary level Intensive Care Unit. J Glob Infect Dis 2016;8:155-9.
Murray PR, Masur H. Current approaches to the diagnosis of bacterial and fungal bloodstream infections in the Intensive Care Unit. Crit Care Med 2012;40:3277-82.
Giri S, Kindo AJ, Kalyani J. Candidemia in Intensive Care Unit patients: A one year study from a tertiary care center in South India. J Postgrad Med 2013;59:190-5.
Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, et al. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med 2015;41:285-95.
Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96.
Gonzalez L, Cravoisy A, Barraud D, Conrad M, Nace L, Lemarié J, et al. Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients. Crit Care 2013;17:R140.
Peterson LR, Hamilton JD, Baron EJ, Tompkins LS, Miller JM, Wilfert CM, et al. Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care. Clin Infect Dis 2001;32:605-11.
Medscape. Enterococcal Infections Treatment and Management. Available from: http://www.emedicine.medscape.com/article/216993-treatment. [Last accessed on 2016 Jul 21].
Britt NS, Potter EM, Patel N, Steed ME. Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: A national cohort study of veterans affairs patients. Clin Infect Dis 2015;61:871-8.
Rybak MJ, Hershberger E, Moldovan T, Grucz RG.In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin- intermediate and -resistant strains. Antimicrob Agents Chemother 2000;44:1062-6.
Kainer MA, Devasia RA, Jones TF, Simmons BP, Melton K, Chow S, et al. Response to emerging infection leading to outbreak of linezolid-resistant enterococci. Emerg Infect Dis 2007;13:1024-30.
Poutsiaka DD, Skiffington S, Miller KB, Hadley S, Snydman DR. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients. J Infect 2007;54:567-71.
Ramaswamy DP, Amodio-Groton M, Scholand SJ. Use of daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections: A short case series. BMC Urol 2013;13:33.
Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: Importance of combination therapy. Clin Infect Dis 2012;55:943-50.
El-Halfawy OM, Valvano MA. Antimicrobial heteroresistance: An emerging field in need of clarity. Clin Microbiol Rev 2015;28:191-207.
De Pascale G, Montini L, Pennisi M, Bernini V, Maviglia R, Bello G, et al. High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria. Crit Care 2014;18:R90.
Quintiliani R Sr., Quintiliani R Jr. Pharmacokinetics/Pharmacodynamics for critical care clinicians. Crit Care Clin 2008;24:335-48, xi.
Vasoo S, Cunningham SA, Cole NC, Kohner PC, Menon SR, Krause KM, et al. In vitro activities of ceftazidime-avibactam, aztreonam-avibactam, and a panel of older and contemporary antimicrobial agents against carbapenemase-producing Gram-negative bacilli. Antimicrob Agents Chemother 2015;59:7842-6.
Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study. Lancet Infect Dis 2016;16:161-8.
Scheetz MH, Hurt KM, Noskin GA, Oliphant CM. Applying antimicrobial pharmacodynamics to resistant Gram-negative pathogens. Am J Health Syst Pharm 2006;63:1346-60.
Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Executive summary: Implementing an antibiotic stewardship program: Guidelines by the infectious diseases society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62:1197-202.
Zabarsky TF, Sethi AK, Donskey CJ. Sustained reduction in inappropriate treatment of asymptomatic bacteriuria in a long-term care facility through an educational intervention. Am J Infect Control 2008;36:476-80.
Oberoi JK, Wattal C, Goel N, Raveendran R, Datta S, Prasad K. Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India. Indian J Med Res 2012;136:997-1003.
Adanir T, Sencan A, Dereli Y, Dinler A, Aran G, Karahan N. Effects of candiduria-candidemia infections on mortality and morbidity in the ICU and the risk factors of these infections. Crit Care 2006;10 Suppl 1:141.
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Executive summary: Clinical practice guideline for the management of candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016;62:409-17.
Wattal C, Chakrabarti A, Oberoi JK, Donnelly JP, Barnes RA, Sherwal BL, et al. Issues in antifungal stewardship: An opportunity that should not be lost. J Antimicrob Chemother 2016. pii: dkw506.
Gross R, Morgan AS, Kinky DE, Weiner M, Gibson GA, Fishman NO. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 2001;33:289-95.
Pope SD, Dellit TH, Owens RC, Hooton TM; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Infect Control Hosp Epidemiol 2009;30:97-8.
Archibald LK. Medscape Infectious Diseases. Rapid Diagnostic Testing of Infectious Diseases. Available from: http://www.medscape.com/viewarticle/748139_1. [Last accessed on 2016 Jul 21].
O'Horo JC, Thompson D, Safdar N. Is the gram stain useful in the microbiologic diagnosis of VAP? A meta-analysis. Clin Infect Dis 2012;55:551-61.
Salez N, Vabret A, Leruez-Ville M, Andreoletti L, Carrat F, Renois F, et al. Evaluation of four commercial multiplex molecular tests for the diagnosis of acute respiratory infections. PLoS One 2015;10:e0130378.
Castagnola E, Furfaro E, Caviglia I, Licciardello M, Faraci M, Fioredda F, et al. Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation. Clin Microbiol Infect 2010;16:1197-203.